The collaboration between T2 Biosystems and Vanderbilt University Medical Center combines T2's diagnostic technology with Vanderbilt's clinical expertise. This partnership may lead to improved patient care and outcomes, which could increase the demand for T2's products and services, positively impacting the company's stock price in the short term.